Trial of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation

NCT00948818 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

803

Enrollment

INDUSTRY

Sponsor class

Conditions

Irritable Bowel Syndrome Characterized by Constipation

Interventions

DRUG: Linaclotide 290 micrograms
DRUG: Matching placebo

Sponsor

Forest Laboratories

Collaborators

[object Object]